SAMPLE - MarketResearch · 16.3.5 Biosensors Enters Into Licensing Agreement With Eurocor ..... 187 16.3.6 CardioDx And Core Diagnostics Enter Into Co-Marketing Agreement For Corus
Post on 17-Feb-2020
1 Views
Preview:
Transcript
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 1
India Cardiovascular Devices Market
Outlook to 2020
Reference Code: GDMEMC0040DB
Publication Date: May 2014
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 2
1 Table of Contents
1 Table of Contents .................................................................................................................................................... 2
1.1 List of Tables .................................................................................................................................................... 7
1.2 List of Figures ................................................................................................................................................. 10
2 Introduction ............................................................................................................................................................ 12
2.1 What Is This Report About? ........................................................................................................................... 12
2.2 Cardiovascular Devices Market Segmentation .............................................................................................. 12
2.3 Definitions of Markets Covered in the Report ................................................................................................ 15
3 Cardiovascular Devices Market, India ................................................................................................................. 31
3.1 Cardiovascular Devices Market, India, Revenue ($m), 2005-2020 ............................................................... 31
3.2 Cardiovascular Devices Market, India, Revenue Mix ($m), 2012 .................................................................. 33
3.3 Cardiovascular Devices Market, India, Category Contribution by Revenue ($m), 2012 ............................... 34
3.4 Cardiovascular Devices Market, India, Category Comparison by Revenue ($m), 2005-2020 ...................... 36
3.5 Cardiovascular Devices Market, India, Revenue ($m), 2005-2012 ............................................................... 38
3.6 Cardiovascular Devices Market, India, Revenue ($m), 2012-2020 ............................................................... 40
3.7 Cardiovascular Devices Market, India, Volume (Units), 2005-2020 .............................................................. 42
3.8 Cardiovascular Devices Market, India, Volume (Units), 2005-2012 .............................................................. 44
3.9 Cardiovascular Devices Market, India, Volume (Units), 2012-2020 .............................................................. 46
3.10 Cardiovascular Devices Market, India, Company Share by Revenue ($m), 2011-2012 ............................... 48
4 Cardiac Assist Devices Market, India .................................................................................................................. 50
4.1 Cardiac Assist Devices Market, India, Revenue Mix ($m), 2012 ................................................................... 50
4.2 Cardiac Assist Devices Market, India, Segment Contribution (%), 2012 ....................................................... 51
4.3 Cardiac Assist Devices Market, India, Revenue ($m), by Segment, 2005-2012 ........................................... 52
4.4 Cardiac Assist Devices Market, India, Revenue ($m) by Segment, 2012-2020 ............................................ 54
4.5 Cardiac Assist Devices Market, India, Volume (Units) by Segment, 2005-2012 ........................................... 56
4.6 Cardiac Assist Devices Market, India, Volume (Units) by Segment, 2012-2020 ........................................... 58
4.7 Cardiac Assist Devices Market, India, Distribution Share, Revenue ($m), 2011-2012 ................................. 60
4.8 Cardiac Assist Devices Market, India, Company Share by Revenue ($m), 2011-2012 ................................ 61
5 Cardiac Rhythm Management Market, India ....................................................................................................... 63
5.1 Cardiac Rhythm Management Market, India, Revenue Mix ($m), 2012 ........................................................ 63
5.2 Cardiac Rhythm Management Market, India, Segment Contribution (%), 2012 ............................................ 64
5.3 Cardiac Rhythm Management Market, India, Revenue ($m), by Segment, 2005-2012 ................................ 65
5.4 Cardiac Rhythm Management Market, India, Revenue ($m) by Segment, 2012-2020 ................................. 67
5.5 Cardiac Rhythm Management Market, India, Volume (Units) by Segment, 2005-2012 ................................ 69
5.6 Cardiac Rhythm Management Market, India, Volume (Units) by Segment, 2012-2020 ................................ 71
5.7 Cardiac Rhythm Management Market, India, Distribution Share, Revenue ($m), 2011-2012 ...................... 73
5.8 Cardiac Rhythm Management Market, India, Company Share by Revenue ($m), 2011-2012 ..................... 74
6 Cardiovascular Monitoring and Diagnostic Devices Market, India .................................................................. 76
6.1 Cardiovascular Monitoring and Diagnostic Devices Market, India, Revenue ($m), by Segment, 2005-201276
6.2 Cardiovascular Monitoring and Diagnostic Devices Market, India, Revenue ($m) by Segment, 2012-2020 77
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 3
6.3 Cardiovascular Monitoring and Diagnostic Devices Market, India, Volume (Units) by Segment, 2005-201278
6.4 Cardiovascular Monitoring and Diagnostic Devices Market, India, Volume (Units) by Segment, 2012-202079
6.5 Cardiovascular Monitoring and Diagnostic Devices Market, India, Distribution Share, Revenue ($m), 2011-2012 80
6.6 Cardiovascular Monitoring and Diagnostic Devices Market, India, Company Share by Revenue ($m), 2011-2012 81
7 Cardiovascular Prosthetic Devices Market, India .............................................................................................. 83
7.1 Cardiovascular Prosthetic Devices Market, India, Revenue Mix ($m), 2012 ................................................. 83
7.2 Cardiovascular Prosthetic Devices Market, India, Segment Contribution (%), 2012 ..................................... 84
7.3 Cardiovascular Prosthetic Devices Market, India, Revenue ($m), by Segment, 2005-2012 ......................... 85
7.4 Cardiovascular Prosthetic Devices Market, India, Revenue ($m) by Segment, 2012-2020 .......................... 87
7.5 Cardiovascular Prosthetic Devices Market, India, Volume (Units) by Segment, 2005-2012 ......................... 89
7.6 Cardiovascular Prosthetic Devices Market, India, Volume (Units) by Segment, 2012-2020 ......................... 91
7.7 Cardiovascular Prosthetic Devices Market, India, Distribution Share, Revenue ($m), 2011-2012 ............... 93
7.8 Cardiovascular Prosthetic Devices Market, India, Company Share by Revenue ($m), 2011-2012 .............. 94
8 Cardiovascular Surgery Market, India ................................................................................................................. 96
8.1 Cardiovascular Surgery Market, India, Revenue Mix ($m), 2012 .................................................................. 96
8.2 Cardiovascular Surgery Market, India, Segment Contribution (%), 2012 ...................................................... 97
8.3 Cardiovascular Surgery Market, India, Revenue ($m), by Segment, 2005-2012 .......................................... 98
8.4 Cardiovascular Surgery Market, India, Revenue ($m) by Segment, 2012-2020 ......................................... 100
8.5 Cardiovascular Surgery Market, India, Volume (Units) by Segment, 2005-2012 ........................................ 102
8.6 Cardiovascular Surgery Market, India, Volume (Units) by Segment, 2012-2020 ........................................ 104
8.7 Cardiovascular Surgery Market, India, Distribution Share, Revenue ($m), 2011-2012............................... 106
8.8 Cardiovascular Surgery Market, India, Company Share by Revenue ($m), 2011-2012 ............................. 107
9 Electrophysiology Market, India ........................................................................................................................ 109
9.1 Electrophysiology Market, India, Revenue Mix ($m), 2012.......................................................................... 109
9.2 Electrophysiology Market, India, Segment Contribution (%), 2012 ............................................................. 110
9.3 Electrophysiology Market, India, Revenue ($m), by Segment, 2005-2012 .................................................. 111
9.4 Electrophysiology Market, India, Revenue ($m) by Segment, 2012-2020................................................... 113
9.5 Electrophysiology Market, India, Volume (Units) by Segment, 2005-2012 .................................................. 115
9.6 Electrophysiology Market, India, Volume (Units) by Segment, 2012-2020 .................................................. 117
9.7 Electrophysiology Market, India, Distribution Share, Revenue ($m), 2011-2012 ........................................ 119
9.8 Electrophysiology Market, India, Company Share by Revenue ($m), 2011-2012 ....................................... 120
10 External Defibrillators Market, India ............................................................................................................... 122
10.1 External Defibrillators Market, India, Revenue ($m), by Segment, 2005-2012 ........................................... 122
10.2 External Defibrillators Market, India, Revenue ($m) by Segment, 2012-2020............................................. 123
10.3 External Defibrillators Market, India, Volume (Units) by Segment, 2005-2012 ........................................... 124
10.4 External Defibrillators Market, India, Volume (Units) by Segment, 2012-2020 ........................................... 125
10.5 External Defibrillators Market, India, Distribution Share, Revenue ($m), 2011-2012 .................................. 126
10.6 External Defibrillators Market, India, Company Share by Revenue ($m), 2011-2012 ................................. 127
11 Interventional Cardiology Market, India ......................................................................................................... 129
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 4
11.1 Interventional Cardiology Market, India, Revenue Mix ($m), 2012 .............................................................. 129
11.2 Interventional Cardiology Market, India, Segment Contribution (%), 2012 .................................................. 130
11.3 Interventional Cardiology Market, India, Revenue ($m), by Segment, 2005-2012 ...................................... 131
11.4 Interventional Cardiology Market, India, Revenue ($m), 2012-2020 ........................................................... 133
11.5 Interventional Cardiology Market, India, Volume (Units) by Segment, 2005-2012 ...................................... 135
11.6 Interventional Cardiology Market, India, Volume (Units) by Segment, 2012-2020 ...................................... 137
11.7 Interventional Cardiology Market, India, Distribution Share, Revenue ($m), 2011-2012 ............................ 139
11.8 Interventional Cardiology Market, India, Company Share by Revenue ($m), 2011-2012 ........................... 140
12 Peripheral Vascular Devices Market, India .................................................................................................... 142
12.1 Peripheral Vascular Devices Market, India, Revenue Mix ($m), 2012 ........................................................ 142
12.2 Peripheral Vascular Devices Market, India, Segment Contribution (%), 2012 ............................................ 143
12.3 Peripheral Vascular Devices Market, India, Revenue ($m), by Segment, 2005-2012 ................................ 145
12.4 Peripheral Vascular Devices Market, India, Revenue ($m) by Segment, 2012-2020 ................................. 147
12.5 Peripheral Vascular Devices Market, India, Volume (Units) by Segment, 2005-2012 ................................ 149
12.6 Peripheral Vascular Devices Market, India, Volume (Units) by Segment, 2012-2020 ................................ 151
12.7 Peripheral Vascular Devices Market, India, Distribution Share, Revenue ($m), 2011-2012 ....................... 153
12.8 Peripheral Vascular Devices Market, India, Company Share by Revenue ($m), 2011-2012 ...................... 154
13 Prosthetic Heart Valves Market, India ............................................................................................................ 156
13.1 Prosthetic Heart Valves Market, India, Revenue Mix ($m), 2012 ................................................................ 156
13.2 Prosthetic Heart Valves Market, India, Segment Contribution (%), 2012 .................................................... 157
13.3 Prosthetic Heart Valves Market, India, Revenue ($m), by Segment, 2005-2012 ........................................ 158
13.4 Prosthetic Heart Valves Market, India, Revenue ($m) by Segment, 2012-2020 ......................................... 160
13.5 Prosthetic Heart Valves Market, India, Volume (Units) by Segment, 2005-2012 ........................................ 162
13.6 Prosthetic Heart Valves Market, India, Volume (Units) by Segment, 2012-2020 ........................................ 164
13.7 Prosthetic Heart Valves Market, India, Distribution Share, Revenue ($m), 2011-2012............................... 166
13.8 Prosthetic Heart Valves Market, India, Company Share by Revenue ($m), 2011-2012 ............................. 167
14 Overview of Key Companies in India, Cardiovascular Devices Market ...................................................... 169
14.1 Medtronic, Inc. .............................................................................................................................................. 169
14.1.1 Company Overview .............................................................................................................................. 169
14.2 Terumo Corporation ..................................................................................................................................... 169
14.2.1 Company Overview .............................................................................................................................. 169
14.3 Abbott Laboratories ...................................................................................................................................... 169
14.3.1 Company Overview .............................................................................................................................. 169
14.4 St. Jude Medical, Inc. ................................................................................................................................... 170
14.4.1 Company Overview .............................................................................................................................. 170
14.5 Boston Scientific Corporation ....................................................................................................................... 170
14.5.1 Company Overview .............................................................................................................................. 170
14.6 Edwards Lifesciences Corporation............................................................................................................... 170
14.6.1 Company Overview .............................................................................................................................. 170
14.7 Vascular Concepts Limited .......................................................................................................................... 171
14.7.1 Company Overview .............................................................................................................................. 171
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 5
14.8 Philips Healthcare ........................................................................................................................................ 171
14.8.1 Company Overview .............................................................................................................................. 171
14.9 Maquet Holding B.V. & Co. KG. ................................................................................................................... 171
14.9.1 Company Overview .............................................................................................................................. 171
14.10 Asahi Intecc Co., Ltd. ............................................................................................................................... 172
14.10.1 Company Overview .............................................................................................................................. 172
14.11 Biotronik SE & Co. KG ............................................................................................................................. 172
14.11.1 Company Overview .............................................................................................................................. 172
14.12 Volcano Corporation................................................................................................................................. 172
14.12.1 Company Overview .............................................................................................................................. 172
14.13 Sahajanand Medical Technologies Pvt. Ltd. ............................................................................................ 173
14.13.1 Company Overview .............................................................................................................................. 173
14.14 Biosense Webster, Inc. ............................................................................................................................ 173
14.14.1 Company Overview .............................................................................................................................. 173
14.15 Thoratec Corporation ............................................................................................................................... 173
14.15.1 Company Overview .............................................................................................................................. 173
14.16 Cordis Corporation ................................................................................................................................... 174
14.16.1 Company Overview .............................................................................................................................. 174
14.17 Nihon Kohden Corporation ....................................................................................................................... 174
14.17.1 Company Overview .............................................................................................................................. 174
14.18 Fukuda Denshi Co., Ltd. .......................................................................................................................... 174
14.18.1 Company Overview .............................................................................................................................. 174
14.19 Sorin S.p.A. .............................................................................................................................................. 175
14.19.1 Company Overview .............................................................................................................................. 175
15 Cardiovascular Devices Market Pipeline Products ...................................................................................... 176
16 Financial Deals Landscape ............................................................................................................................. 178
16.1 Acquisition .................................................................................................................................................... 178
16.1.1 Goldman Sachs Rumored To Acquire 26% Stake In Opto Circuits For US$48 Million ....................... 178
16.1.2 Skanray Healthcare Completes Acquisition Of L&T Medical ............................................................... 179
16.2 Asset Transactions ....................................................................................................................................... 181
16.2.1 AngioDynamics Completes Acquisition Of Rights To Microwave Ablation Technology For US$16 Million 181
16.3 Partnerships ................................................................................................................................................. 183
16.3.1 Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology ................. 183
16.3.2 Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse .............................. 184
16.3.3 Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 185
16.3.4 Coherex Medical Enters Into Distribution Agreement With Biosense Webster ................................... 186
16.3.5 Biosensors Enters Into Licensing Agreement With Eurocor ................................................................ 187
16.3.6 CardioDx And Core Diagnostics Enter Into Co-Marketing Agreement For Corus CAD Diagnostic Test 189
16.3.7 Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters .............. 190
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 6
16.3.8 Terumo Enters Into Agreement With Shanghai AngioCare Medical Technolgy .................................. 191
16.3.9 Biosensors Extends Licensing Agreement With Terumo For BioMatrix Technology .......................... 192
16.4 Private Equity ............................................................................................................................................... 193
16.4.1 Goldman Sachs To Acquire 49% Stake In BPL Medical For US$20 Million ........................................ 193
16.4.2 Relisys Medical Devices Plans To Raise US$15 Million In Private Equity Financing ......................... 194
17 Recent Developments ...................................................................................................................................... 195
17.1 Corporate Communications ......................................................................................................................... 195
17.1.1 Apr 22, 2014: Sectra secures large mammography PACS order: Northern Ireland expands its region-wide healthcare imaging IT solution with digital breast imaging ........................................................................... 195
17.2 Financial Announcements ............................................................................................................................ 196
17.2.1 Dec 19, 2013: Withdrawal of NTCELL pre-clinical study ..................................................................... 196
17.2.2 May 27, 2013: TTK Healthcare Reports Revenue Of INR3.8 Billion In Fiscal 2013 ............................ 197
17.3 Other Significant Developments ................................................................................................................... 197
17.3.1 Oct 29, 2013: SHL Telemedicine signs agreement with India's third largest healthcare group, Manipal Hospitals. Expands into Bangalore. ....................................................................................................................... 197
17.3.2 Aug 27, 2013: SHL signs another agreement with hospital in Delhi .................................................... 197
17.4 Product News ............................................................................................................................................... 197
17.4.1 Nov 06, 2013: GE Healthcare To Ship Low-cost Medical Devices From India To Emerging Markets 197
17.5 Strategy And Business Planning .................................................................................................................. 198
17.5.1 Oct 23, 2013: GE Healthcare Aims For 15–20% Growth In India During Fiscal 2013 ........................ 198
18 Appendix ........................................................................................................................................................... 199
18.1 Research Methodology ................................................................................................................................ 200
18.1.1 Coverage .............................................................................................................................................. 200
18.1.2 Secondary Research ............................................................................................................................ 200
18.1.3 Primary Research ................................................................................................................................. 201
18.1.4 Market Modeling and Forecasting ........................................................................................................ 202
18.1.5 Company Share Analysis ..................................................................................................................... 205
18.1.6 Distribution Share Analysis .................................................................................................................. 206
18.2 Expert Panel ................................................................................................................................................. 206
18.3 GlobalData Consulting ................................................................................................................................. 207
18.5 Disclaimer ..................................................................................................................................................... 207
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 7
1.1 List of Tables
Table 1: Cardiovascular Devices Market, India, Revenue ($m), USD Constant, 2005-2020 .......................................................... 32
Table 2: Cardiovascular Devices Market, India, Category Contribution by Revenue ($m), 2012 ................................................... 35
Table 3: Cardiovascular Devices Market, India, Category Comparison by Revenue ($m), 2005-2020 .......................................... 37
Table 4: Cardiovascular Devices Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ............................................ 39
Table 5: Cardiovascular Devices Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 .......................................... 41
Table 6: Cardiovascular Devices Market, India, Volume (Units), 2005-2020.................................................................................. 43
Table 7: Cardiovascular Devices Market, India, Volume (Units), Historic, 2005-2012 .................................................................... 45
Table 8: Cardiovascular Devices Market, India, Volume (Units), Forecast, 2012-2020 .................................................................. 47
Table 9: Cardiovascular Devices Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 .......................... 49
Table 10: Cardiac Assist Devices Market, India, Segment Contribution (%), 2012 ........................................................................ 51
Table 11: Cardiac Assist Devices Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ........................................... 53
Table 12: Cardiac Assist Devices Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 .......................................... 55
Table 13: Cardiac Assist Devices Market, India, Volume (Units), Historic, 2005-2012 ................................................................... 57
Table 14: Cardiac Assist Devices Market, India, Volume (Units), Forecast, 2012-2020 ................................................................. 59
Table 15: Cardiac Assist Devices Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ....................... 60
Table 16: Cardiac Assist Devices Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 ......................... 62
Table 17: Cardiac Rhythm Management Market, India, Segment Contribution (%), 2012 ............................................................. 64
Table 18: Cardiac Rhythm Management Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ................................ 66
Table 19: Cardiac Rhythm Management Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ............................... 68
Table 20: Cardiac Rhythm Management Market, India, Volume (Units), Historic, 2005-2012 ........................................................ 70
Table 21: Cardiac Rhythm Management Market, India, Volume (Units), Forecast, 2012-2020 ...................................................... 72
Table 22: Cardiac Rhythm Management Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ............ 73
Table 23: Cardiac Rhythm Management Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 .............. 75
Table 24: Cardiovascular Monitoring and Diagnostic Devices Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 76
Table 25: Cardiovascular Monitoring and Diagnostic Devices Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020
......................................................................................................................................................................................................... 77
Table 26: Cardiovascular Monitoring and Diagnostic Devices Market, India, Volume (Units), Historic, 2005-2012 ....................... 78
Table 27: Cardiovascular Monitoring and Diagnostic Devices Market, India, Volume (Units), Forecast, 2012-2020 ..................... 79
Table 28: Cardiovascular Monitoring and Diagnostic Devices Market, India, Distribution Share by Revenue ($m), USD Constant,
2011-2012 ........................................................................................................................................................................................ 80
Table 29: Cardiovascular Monitoring and Diagnostic Devices Market, India, Company Share by Revenue ($m), USD Constant,
2011-2012 ........................................................................................................................................................................................ 82
Table 30: Cardiovascular Prosthetic Devices Market, India, Segment Contribution (%), 2012 ...................................................... 84
Table 31: Cardiovascular Prosthetic Devices Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ......................... 86
Table 32: Cardiovascular Prosthetic Devices Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ........................ 88
Table 33: Cardiovascular Prosthetic Devices Market, India, Volume (Units), Historic, 2005-2012 ................................................. 90
Table 34: Cardiovascular Prosthetic Devices Market, India, Volume (Units), Forecast, 2012-2020 ............................................... 92
Table 35: Cardiovascular Prosthetic Devices Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ..... 93
Table 36: Cardiovascular Prosthetic Devices Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 ....... 95
Table 37: Cardiovascular Surgery Market, India, Segment Contribution (%), 2012 ....................................................................... 97
Table 38: Cardiovascular Surgery Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 .......................................... 99
Table 39: Cardiovascular Surgery Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ....................................... 101
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 8
Table 40: Cardiovascular Surgery Market, India, Volume (Units), Historic, 2005-2012 ................................................................ 103
Table 41: Cardiovascular Surgery Market, India, Volume (Units), Forecast, 2012-2020 .............................................................. 105
Table 42: Cardiovascular Surgery Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 .................... 106
Table 43: Cardiovascular Surgery Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 ...................... 108
Table 44: Electrophysiology Market, India, Segment Contribution (%), 2012 ............................................................................... 110
Table 45: Electrophysiology Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ................................................. 112
Table 46: Electrophysiology Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ................................................ 114
Table 47: Electrophysiology Market, India, Volume (Units), Historic, 2005-2012 ......................................................................... 116
Table 48: Electrophysiology Market, India, Volume (Units), Forecast, 2012-2020 ....................................................................... 118
Table 49: Electrophysiology Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ............................. 119
Table 50: Electrophysiology Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 ................................ 121
Table 51: External Defibrillators Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ........................................... 122
Table 52: External Defibrillators Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 .......................................... 123
Table 53: External Defibrillators Market, India, Volume (Units), Historic, 2005-2012 ................................................................... 124
Table 54: External Defibrillators Market, India, Volume (Units), Forecast, 2012-2020 ................................................................. 125
Table 55: External Defibrillators Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ....................... 126
Table 56: External Defibrillators Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 .......................... 128
Table 57: Interventional Cardiology Market, India, Segment Contribution (%), 2012 ................................................................... 130
Table 58: Interventional Cardiology Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ...................................... 132
Table 59: Interventional Cardiology Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ..................................... 134
Table 60: Interventional Cardiology Market, India, Volume (Units), Historic, 2005-2012 .............................................................. 136
Table 61: Interventional Cardiology Market, India, Volume (Units), Forecast, 2012-2020 ............................................................ 138
Table 62: Interventional Cardiology Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 .................. 139
Table 63: Interventional Cardiology Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 .................... 141
Table 64: Peripheral Vascular Devices Market, India, Segment Contribution (%), 2012 .............................................................. 144
Table 65: Peripheral Vascular Devices Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ................................ 146
Table 66: Peripheral Vascular Devices Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ............................... 148
Table 67: Peripheral Vascular Devices Market, India, Volume (Units), Historic, 2005-2012 ........................................................ 150
Table 68: Peripheral Vascular Devices Market, India, Volume (Units), Forecast, 2012-2020 ...................................................... 152
Table 69: Peripheral Vascular Devices Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ............ 153
Table 70: Peripheral Vascular Devices Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 ............... 155
Table 71: Prosthetic Heart Valves Market, India, Segment Contribution (%), 2012 ..................................................................... 157
Table 72: Prosthetic Heart Valves Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ........................................ 159
Table 73: Prosthetic Heart Valves Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ....................................... 161
Table 74: Prosthetic Heart Valves Market, India, Volume (Units), Historic, 2005-2012 ................................................................ 163
Table 75: Prosthetic Heart Valves Market, India, Volume (Units), Forecast, 2012-2020 .............................................................. 165
Table 76: Prosthetic Heart Valves Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 .................... 166
Table 77: Prosthetic Heart Valves Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 ...................... 168
Table 78: Cardiovascular Devices Market Pipeline Products ....................................................................................................... 176
Table 79: Goldman Sachs Rumored To Acquire 26% Stake In Opto Circuits For US$48 Million ................................................. 178
Table 80: Skanray Healthcare Completes Acquisition Of L&T Medical ........................................................................................ 179
Table 81: AngioDynamics Completes Acquisition Of Rights To Microwave Ablation Technology For US$16 Million .................. 181
Table 82: Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology ........................................... 183
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 9
Table 83: Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse ........................................................ 184
Table 84: Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems ...... 185
Table 85: Coherex Medical Enters Into Distribution Agreement With Biosense Webster ............................................................. 186
Table 86: Biosensors Enters Into Licensing Agreement With Eurocor ......................................................................................... 187
Table 87: CardioDx And Core Diagnostics Enter Into Co-Marketing Agreement For Corus CAD Diagnostic Test ....................... 189
Table 88: Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters ........................................ 190
Table 89: Terumo Enters Into Agreement With Shanghai AngioCare Medical Technolgy ........................................................... 191
Table 90: Biosensors Extends Licensing Agreement With Terumo For BioMatrix Technology .................................................... 192
Table 91: Goldman Sachs To Acquire 49% Stake In BPL Medical For US$20 Million ................................................................. 193
Table 92: Relisys Medical Devices Plans To Raise US$15 Million In Private Equity Financing ................................................... 194
Table 93: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country .................................... 202
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 10
1.2 List of Figures
Figure 1: Cardiovascular Devices Market, India, Revenue ($m), USD Constant, 2005-2020......................................................... 31
Figure 2: Cardiovascular Devices Market, India, Revenue Mix ($m), 2012 .................................................................................... 33
Figure 3: Cardiovascular Devices Market, India, Category Contribution (%), 2012 ........................................................................ 34
Figure 4: Cardiovascular Devices Market, India, Category Comparison by Revenue ($m), 2005-2020 ......................................... 36
Figure 5: Cardiovascular Devices Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ........................................... 38
Figure 6: Cardiovascular Devices Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 ......................................... 40
Figure 7: Cardiovascular Devices Market, India, Volume (Units), 2005-2020 ................................................................................ 42
Figure 8: Cardiovascular Devices Market, India, Volume (Units), Historic, 2005-2012 .................................................................. 44
Figure 9: Cardiovascular Devices Market, India, Volume (Units), Forecast, 2012-2020 ................................................................ 46
Figure 10: Cardiovascular Devices Market, India, Company Share (%), 2012 ............................................................................... 48
Figure 11: Cardiac Assist Devices Market, India, Revenue Mix ($m), 2012 ................................................................................... 50
Figure 12: Cardiac Assist Devices Market, India, Segment Contribution (%), 2012 ....................................................................... 51
Figure 13: Cardiac Assist Devices Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 .......................................... 52
Figure 14: Cardiac Assist Devices Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ......................................... 54
Figure 15: Cardiac Assist Devices Market, India, Volume (Units), Historic, 2005-2012 ................................................................. 56
Figure 16: Cardiac Assist Devices Market, India, Volume (Units), Forecast, 2012-2020 ............................................................... 58
Figure 17: Cardiac Assist Devices Market, India, Company Share (%), 2012 ................................................................................ 61
Figure 18: Cardiac Rhythm Management Market, India, Revenue Mix ($m), 2012 ........................................................................ 63
Figure 19: Cardiac Rhythm Management Market, India, Segment Contribution (%), 2012 ............................................................ 64
Figure 20: Cardiac Rhythm Management Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ............................... 65
Figure 21: Cardiac Rhythm Management Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 .............................. 67
Figure 22: Cardiac Rhythm Management Market, India, Volume (Units), Historic, 2005-2012....................................................... 69
Figure 23: Cardiac Rhythm Management Market, India, Volume (Units), Forecast, 2012-2020 ..................................................... 71
Figure 24: Cardiac Rhythm Management Market, India, Company Share (%), 2012 ..................................................................... 74
Figure 25: Cardiovascular Monitoring and Diagnostic Devices Market, India, Revenue ($m), USD Constant, Historic, 2005-2012
......................................................................................................................................................................................................... 76
Figure 26: Cardiovascular Monitoring and Diagnostic Devices Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020
......................................................................................................................................................................................................... 77
Figure 27: Cardiovascular Monitoring and Diagnostic Devices Market, India, Volume (Units), Historic, 2005-2012 ...................... 78
Figure 28: Cardiovascular Monitoring and Diagnostic Devices Market, India, Volume (Units), Forecast, 2012-2020 .................... 79
Figure 29: Cardiovascular Monitoring and Diagnostic Devices Market, India, Company Share (%), 2012 .................................... 81
Figure 30: Cardiovascular Prosthetic Devices Market, India, Revenue Mix ($m), 2012 ................................................................. 83
Figure 31: Cardiovascular Prosthetic Devices Market, India, Segment Contribution (%), 2012 ..................................................... 84
Figure 32: Cardiovascular Prosthetic Devices Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ........................ 85
Figure 33: Cardiovascular Prosthetic Devices Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ....................... 87
Figure 34: Cardiovascular Prosthetic Devices Market, India, Volume (Units), Historic, 2005-2012 ................................................ 89
Figure 35: Cardiovascular Prosthetic Devices Market, India, Volume (Units), Forecast, 2012-2020 .............................................. 91
Figure 36: Cardiovascular Prosthetic Devices Market, India, Company Share (%), 2012 .............................................................. 94
Figure 37: Cardiovascular Surgery Market, India, Revenue Mix ($m), 2012 .................................................................................. 96
Figure 38: Cardiovascular Surgery Market, India, Segment Contribution (%), 2012 ...................................................................... 97
Figure 39: Cardiovascular Surgery Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ......................................... 98
Figure 40: Cardiovascular Surgery Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ...................................... 100
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 11
Figure 41: Cardiovascular Surgery Market, India, Volume (Units), Historic, 2005-2012 ............................................................... 102
Figure 42: Cardiovascular Surgery Market, India, Volume (Units), Forecast, 2012-2020 ............................................................. 104
Figure 43: Cardiovascular Surgery Market, India, Company Share (%), 2012 ............................................................................. 107
Figure 44: Electrophysiology Market, India, Revenue Mix ($m), 2012 ......................................................................................... 109
Figure 45: Electrophysiology Market, India, Segment Contribution (%), 2012 .............................................................................. 110
Figure 46: Electrophysiology Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ................................................ 111
Figure 47: Electrophysiology Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ............................................... 113
Figure 48: Electrophysiology Market, India, Volume (Units), Historic, 2005-2012 ........................................................................ 115
Figure 49: Electrophysiology Market, India, Volume (Units), Forecast, 2012-2020 ...................................................................... 117
Figure 50: Electrophysiology Market, India, Company Share (%), 2012 ...................................................................................... 120
Figure 51: External Defibrillators Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 .......................................... 122
Figure 52: External Defibrillators Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ......................................... 123
Figure 53: External Defibrillators Market, India, Volume (Units), Historic, 2005-2012 .................................................................. 124
Figure 54: External Defibrillators Market, India, Volume (Units), Forecast, 2012-2020 ................................................................ 125
Figure 55: External Defibrillators Market, India, Company Share (%), 2012 ................................................................................ 127
Figure 56: Interventional Cardiology Market, India, Revenue Mix ($m), 2012 .............................................................................. 129
Figure 57: Interventional Cardiology Market, India, Segment Contribution (%), 2012 .................................................................. 130
Figure 58: Interventional Cardiology Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ..................................... 131
Figure 59: Interventional Cardiology Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 .................................... 133
Figure 60: Interventional Cardiology Market, India, Volume (Units), Historic, 2005-2012 ............................................................ 135
Figure 61: Interventional Cardiology Market, India, Volume (Units), Forecast, 2012-2020 .......................................................... 137
Figure 62: Interventional Cardiology Market, India, Company Share (%), 2012 ........................................................................... 140
Figure 63: Peripheral Vascular Devices Market, India, Revenue Mix ($m), 2012 ......................................................................... 142
Figure 64: Peripheral Vascular Devices Market, India, Segment Contribution (%), 2012 ............................................................. 143
Figure 65: Peripheral Vascular Devices Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ............................... 145
Figure 66: Peripheral Vascular Devices Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 .............................. 147
Figure 67: Peripheral Vascular Devices Market, India, Volume (Units), Historic, 2005-2012 ....................................................... 149
Figure 68: Peripheral Vascular Devices Market, India, Volume (Units), Forecast, 2012-2020 ..................................................... 151
Figure 69: Peripheral Vascular Devices Market, India, Company Share (%), 2012 ..................................................................... 154
Figure 70: Prosthetic Heart Valves Market, India, Revenue Mix ($m), 2012 ................................................................................ 156
Figure 71: Prosthetic Heart Valves Market, India, Segment Contribution (%), 2012 .................................................................... 157
Figure 72: Prosthetic Heart Valves Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 ....................................... 158
Figure 73: Prosthetic Heart Valves Market, India, Revenue ($m) USD Constant, Forecast, 2012-2020 ...................................... 160
Figure 74: Prosthetic Heart Valves Market, India, Volume (Units), Historic, 2005-2012 ............................................................... 162
Figure 75: Prosthetic Heart Valves Market, India, Volume (Units), Forecast, 2012-2020 ............................................................. 164
Figure 76: Prosthetic Heart Valves Market, India, Company Share (%), 2012 ............................................................................. 167
Figure 77: GlobalData Epidemiology-Based Forecasting Model .................................................................................................. 204
Figure 78: GlobalData Capital Equipment-Based Forecasting Model .......................................................................................... 205
Figure 79: Primary Interviews by Participant Type (%) ................................................................................................................. 206
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 12
2 Introduction
Medical Equipment Market Reports are the ideal guide for anyone wishing to understand their market better in terms
of revenues, unit sales, distributors and competitors.
2.1 What Is This Report About?
This report provides an overview and the following information related to the country, various categories, distribution
share and competitive landscape in the market:
1. Comprehensive data related to the market revenue, unit sale, company share and distribution share.
2. Corporate-level profiles of key companies operating in the Cardiovascular Devices market, which includes a
brief overview of the company. The selection of the companies is based on their operational presence.
3. A list of key products under development by different companies. The selection of this list is based on the
territory in which these products are being clinically investigated.
4. Key news and deals related to the Cardiovascular Devices market.
2.2 Cardiovascular Devices Market Segmentation
Cardiovascular Devices market is segmented into the following categories, as described below, in this report:
Cardiac Assist Devices includes segments such as
1. Total Artificial Heart
2. Intra-Aortic Balloon Pumps
Intra-Aortic Balloon Pumps includes sub-segments such as Intra-Aortic Balloon Pump Catheters and
Intra-Aortic Balloon Pump Consoles
3. Ventricular Assist Devices
Ventricular Assist Devices includes sub-segments such as Biventricular Assist Devices, External
Ventricular Assist Devices, Left Ventricular Assist Devices and Right Ventricular Assist Devices
Cardiac Rhythm Management Devices includes segments such as
1. Implantable Loop Recorders
2. Cardiac Resynchronisation Therapy
Cardiac Resynchronisation Therapy includes sub-segments such as Cardiac Resynchronisation
Therapy - Defibrillators and Cardiac Resynchronisation Therapy - Pacemakers
3. Implantable Cardioverter Defibrillators
Implantable Cardioverter Defibrillators includes Dual Chamber Implantable Cardioverter Defibrillators
and Single Chamber Implantable Cardioverter Defibrillators
4. Pacemakers
Pacemakers includes Dual Chamber Pacemakers and Single Chamber Pacemakers
Cardiovascular Monitoring and Diagnostic Devices includes segments such as
1. Cardiopulmonary Stress Testing Systems
2. ECG Data Management Systems
3. ECG Monitoring Equipment
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 13
4. ECG Stress Testing Systems
5. Event Monitoring Systems
6. Holter Monitoring Systems
Cardiovascular Prosthetic Devices
1. Cardiac Valve Repairs
2. Septal Occluders
Septal Occluders includes sub-segments such as Atrial Septal Defect (ASD) Occluders, Patent
Foramen Ovale (PFO) Occluders and Ventricular Septal Defect (VSD) Occluders
Cardiovascular Surgery Devices includes segments such as
1. Cardiac Ablation Devices
2. Cardiopulmonary Bypass Equipment
3. Beating Heart Surgery Systems
Beating Heart Surgery Systems includes sub-segments such as Positioners and Stabilizers
4. Perfusion Disposables
Perfusion Disposables includes sub-segments such as Custom Tubing Packs and Oxygenators
Electrophysiology Devices includes segments such as
1. Electrophysiology Lab Systems
2. Electrophysiology Diagnostic Catheters
Electrophysiology Diagnostic Catheters includes sub-segments such as Standard Diagnostic
Catheters and Advanced Diagnostic Catheters
3. Electrophysiology Ablation Catheters
Electrophysiology Ablation Catheters includes sub-segments such as Standard Ablation Catheters
and Advanced Ablation Catheters
External Defibrillators includes segments such as
1. Manual Defibrillators
2. Professional AED
3. Public Access AED
Interventional Cardiology includes segments such as
1. PTCA Coronary Drug Eluting Balloons (DEB)
2. Coronary Guidewires
3. Arteriotomy Closure Devices
Arteriotomy Closure Devices includes sub-segments such as Femoral Access Devices and Radial
Access Devices
4. Cardiac Catheters
Cardiac Catheters includes sub-segments such as Angiography Catheters and Guiding Catheters
5. Coronary Stents
Coronary Stents includes sub-segments such as Bare Metal Stents and Drug Eluting Stents (DES)
6. Intravascular Ultrasound Systems (IVUS)
Intravascular Ultrasound Systems (IVUS) includes sub-segments such as Intravascular Ultrasound
Catheters and Intravascular Ultrasound System Consoles
7. PTCA Balloons
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 14
PTCA Balloons includes sub-segments such as FW Balloons, Over the Wire Balloons, PTCA Cutting
and Scoring Balloons and Rx Balloons
Peripheral Vascular Devices includes segments such as
1. Renal Denervation Disposable Catheters
2. PTA Balloons
3. PTA Peripheral Drug Eluting Balloons (DEB)
4. Inferior Vena Cava Filters (IVCF)
Inferior Vena Cava Filters (IVCF) includes sub-segments such as Permanent IVCF and Retrievable
IVCF
5. Peripheral Embolic Protection Devices
Peripheral Embolic Protection Devices includes sub-segments such as Carotid Embolic Protection
Devices, Lower Extremity Embolic Protection Devices and Renal Embolic Protection Devices
6. Peripheral Guidewires
Peripheral Guidewires includes sub-segments such as Hydrophilic Peripheral Guidewires and Non-
Hydrophilic Peripheral Guidewires
7. Peripheral Vascular Stents
Peripheral Vascular Stents includes sub-segments such as Carotid Artery Bare Metal Stents, Fem-
pop Artery Stents (Fem-pop Artery Bare Metal Stents, Fem-pop Artery Bioabsorbable Stents, Fem-
pop Artery Covered Stents and Fem-pop Artery Drug Eluting Stents), Iliac Artery Stents (Iliac Artery
Bare Metal Stents, Iliac Artery Bioabsorbable Stents, Iliac Artery Covered Stents and Iliac Artery
Drug Eluting Stents), Infrapop Artery Stents (Infrapop Artery Bare Metal Stents, Infrapop Artery
Bioabsorbable Stents, Infrapop Artery Covered Stents and Infrapop Artery Drug Eluting Stents) and
Renal Artery Bare Metal Stents
8. Aortic Stent Grafts
Aortic Stent Grafts includes sub-segments such as Abdominal Aortic Stent Grafts and Thoracic
Aortic Stent Grafts
9. Vascular Grafts
10. Peripheral Venous Thrombectomy Devices
Peripheral Venous Thrombectomy Devices includes sub-segments such as Mechanical
Thrombectomy Devices and Aspiration Thrombectomy Devices
Prosthetic Heart Valves includes segments such as
1. Transcatheter Heart Valves
2. Mechanical Heart Valves
Mechanical Heart Valves includes sub-segments such as Mechanical Aortic Valve Replacements
and Mechanical Mitral Valve Replacements
3. Tissue Heart Valves
Tissue Heart Valves includes sub-segments such as Tissue Aortic Valve Replacements and Tissue
Mitral Valve Replacements SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 15
2.3 Definitions of Markets Covered in the Report
Cardiac Assist Devices
Cardiac assist devices are used to support the failing heart which cannot be managed with standard medical therapy.
These devices can be used for both short term and long term purposes allowing the heart to rest long enough so that
it can return to normal. Cardiac assist devices include Total Artificial Heart (TAH) devices, Ventricular Assist Devices
(VAD) and Intra-Aortic Balloon Pumps (IABP).
Total Artificial Heart
A total artificial heart is a prosthetic device that is implanted into the body to replace the biological heart. One unit
refers to one total artificial heart.
Ventricular Assist Devices
A Ventricular Assist Device (VAD) is a mechanical pump that helps a heart that is too weak to pump blood through
the body. It is sometimes referred to as “a bridge to transplant” since it can help a patient survive until a heart
transplant can be performed.
Left Ventricular Assist Devices
A left ventricular assist device is a ventricular assist system intended for the treatment of advanced-stage heart failure. It assists the left ventricle in pumping the blood. One unit refers to one left ventricular assist device with accessories.
Right Ventricular Assist Devices
A right ventricular assist device is a ventricular assist system intended to assist the right ventricle in pumping the
blood. One unit refers to one right ventricular assist device with accessories.
External Ventricular Assist Devices
An external ventricular assist device is provided for augmenting cardiac contractions. This is connected surgically to
an EKG machine which actuates a fluid pump in response to the QRS waves of the heart. It consists of a flexible,
non-distensible shell adapted to be positioned over the heart base. One unit refers to one external ventricular assist
device with accessories.
Biventricular Assist Devices
Biventricular assist device is a ventricular assist system intended to assist both the ventricles in pumping the blood.
One unit refers to one biventricular assist device with accessories.
Intra-Aortic Balloon Pumps
The Intra-aortic Balloon Pump (IABP) is a mechanical device that is used to decrease myocardial oxygen demand
while at the same time increasing cardiac output. By increasing cardiac output it also increases coronary blood flow
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 16
and therefore myocardial oxygen delivery. It consists of a cylindrical balloon that sits in the aorta and counter
pulsates.
Intra-Aortic Balloon Pump Catheters
Intra-Aortic Balloon Catheters are used in conjunction with Intra-Aortic Balloon Pumps to assist in improving the
cardiac output to meet the oxygen demand of the body. One unit refers to one Intra-Aortic Balloon Pump Catheter.
Intra-Aortic Balloon Pump Consoles
Intra-aortic balloon pump console triggers and optimizes counter pulsation support to patients. The console triggers
the counter pulsatisation based on factors like ECG readings or pressure required. These systems automatically sets
both the inflate and deflate timings. It comes along in a cart with a monitor and an internal battery. One unit refers to
one intra-aortic balloon pump console with all the above mentioned components.
Cardiac Rhythm Management
Cardiac Rhythm Management (CRM) devices are used to restore the natural synchronized pumping rhythm of the
heart. These include pacemakers, Cardiac Resynchronization Therapy (CRT), Implantable Loop Recorders and
Implantable Cardioverter Defibrillators (ICD). These Devices are used for the treatment of congestive heart failure.
Cardiac Resynchronisation Therapy
Cardiac Resynchronization Therapy (CRT) device is used for the treatment of heart failure-induced conduction
disturbances and ventricular dysynchrony. When used in combination with stable, optimal medical therapy, CRT is
designed to reduce symptoms and improve cardiac function by restoring the mechanical sequence of ventricular
activation and contraction.
Cardiac Resynchronisation Therapy – Defibrillators
Cardiac Resynchronisation Therapy – Defibrillator uses an Implantable Cardioverter Defibrillator (ICD) to improve the
coordination of the heart rhythm. This device utilizes three leads, one to the right atrium and one in each of the
ventricles. One unit refers to one cardiac resynchronisation therapy - defibrillator. Leads and electrodes are not
included here.
Cardiac Resynchronisation Therapy – Pacemakers
Cardiac Resynchronisation Therapy – Pacemaker uses a pacemaker device to improve the coordination of the heart
rhythm. This device utilizes three leads, one to the right atrium and one in each of the ventricles. One unit refers to
one cardiac resynchronisation therapy - pacemaker. Leads and electrodes are not included here.
Implantable Cardioverter Defibrillators
An Implantable Cardioverter Defibrillator (ICD) is a device which detects cardiac arrhythmia, or irregular beating of the
heart, and delivers a high voltage shock to restore the natural rhythm. This restores the natural rhythm of the heart.
The ICD is of the single chamber and dual chamber.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 17
Single Chamber Implantable Cardioverter Defibrillators
A single chamber Implantable Cardioverter Defibrillator (ICD) is a device which detects cardiac arrhythmia, or
irregular beating of the heart in one chamber (either an atrium or a ventricle) of the heart, and delivers a high voltage
shock to restore the natural rhythm. One unit refers to one single chamber implantable cardoverter defibrillator. Leads
and electrodes are not included here.
Dual Chamber Implantable Cardioverter Defibrillators
A dual chamber Implantable Cardioverter Defibrillator (ICD) is a device which detects cardiac arrhythmia, or irregular
beating of the heart in two chambers (the atrium or the ventricle) of the heart, and delivers a high voltage shock to
restore the natural rhythm. One unit refers to one dual chamber implantable cardioverter defibrillator. Leads and
electrodes are not included here.
Pacemakers
A pacemaker is a device designed to regulate the beating of the heart by providing electrical impulses delivered by
the electrodes contacting the heart muscle. It can be a single chamber or dual chamber type.
Dual Chamber Pacemakers
Dual chamber pacemakers have pacing leads in two chambers of the heart. One lead paces the atrium and one
paces the ventricle. This approach more closely matches the natural pacing of the heart. These types of pacemaker
can co-ordinate function between the atria and ventricles. Leads and electrodes are not included here. One unit refers
to one dual chamber pacemaker.
Single Chamber Pacemakers
A single chamber pacemaker is a device which has a single pacing lead placed into a chamber of the heart. This
could be the atrium or ventricle. Leads and electrodes are not included here. One unit refers to one single chamber
pacemaker.
Implantable Loop Recorder (ILR)
An Implantable Loop Recorder (ILR) is a subcutaneous, single-lead, electrocardiographic (ECG) monitoring device
used for diagnosis in patients with recurrent unexplained episodes of palpitations or syncope, along with long-term
monitoring in patients at risk for or with atrial fibrillation, structural heart disease, bundle branch block, recurrent
neurally mediated syncope etc. It consists of the insertable recorder that comes with a battery and two surface
electrodes. One unit refers to a single implantable loop recorder.
Cardiovascular Monitoring and Diagnostic Devices
Cardiovascular monitoring and diagnostic devices are used to detect and feedback abnormal episodes of electrical
functioning of the heart. The cardiovascular monitoring and diagnostic devices include Cardiopulmonary Stress
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 18
Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems,
Event Monitoring Systems and Holter Monitoring Systems.
Cardiopulmonary Stress Testing Systems
Cardiopulmonary exercise or cardiopulmonary stress testing is done to non-invasively measure heart rate, cardiac
output, oxygen saturation, ventilation, and gas exchange to bring forth abnormalities not detectable at rest. The test is
used to characterize a patient's primary limitation of exercise tolerance as either cardiac or pulmonary in nature. In
addition, the test also provides an assessment of the response to a specific treatment regime. Physicians now
prescribe cardiopulmonary stress test for both cardiac and pulmonary function tests that help identify or assess
conditions of the heart and lungs. One unit refers to one cardio pulmonary stress testing system.
ECG Data Management Systems
ECG Database Management Systems are used to store and manage patients‟ ECG. It allows to capture and store
auditing information, report the serial ECG changes, and can communicate with other systems, such as hospital
information systems. Hospitals use ECG Data Management Systems to store and retrieve patients‟ ECG data. These
systems are integrated systems and are highly configurable to the individual hospital requirements. Multiple facilities
may share a single system. Only market for the main facility has been sized, not all facilities associated with the main
system. One unit refers to one new installation, upgrades are not considered while estimating the market size.
ECG Monitoring Equipment
Resting ECG equipment records the electrocardiogram (ECG) and is used to evaluate 10 seconds (or a specific time
interval) of electrical activity of the heart so a physician can determine the condition of a patient's heart. Resting ECG
equipment is primarily used for the 12-lead ECG test and is primarily used on a mobile cart or trolley. Resting ECG
equipment is NOT the same as ECG Bedside Patient Monitoring equipment. Single channel ECG machines are not
covered in this segment. One unit refers to one ECG monitoring equipment with more than 3 channels.
ECG Stress Testing Systems
ECG Stress Testing Systems or Tread Mill Testing (TMT) System is used to record ECG of the heart during
excessive workload. The system measures the performance of the heart at various stress levels. This does not
include cost of treadmill. One unit refers to one ECG recorder and PC based software.
Event Monitoring Systems
Event monitors or recorders are devices which record only the abnormal events of the ECG over an extended period
of time. One unit refers to one event monitor or recorder.
Holter Monitoring Systems
Holter monitoring systems record the ECG for a 24 or 48 hour period and are used to identify abnormal episodes of
the heart. The Holter system usually consists of a recorder, an interface circuit board, software for data analysis, and
an audio cassette or digital flash memory device for storage. One unit refers to one Holter monitoring system and a
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 19
glenoid component made of this alloy or a combination of this alloy and ultra-high molecular weight polyethylene. One
unit is one implant set.
Cardiovascular Prosthetic Devices
Cardiovascular prosthetic devices are used to improve the survival and quality of life, treat chronic heart valve
conditions.
Cardiac Valve Repairs
Cardiac valve repair devices are used in the repair of malfunctioning valves. Only mitral valve repair has been
covered under this segment. Tricuspid and Aortic annuloplasty rings are not included here. One unit refers to one
annuloplasty cardiac valve repair ring.
Annuloplasty is a technique used to repair an enlarged annulus; a ring is placed at the base of the heart valve. This
annuloplasty ring makes the opening of valve smaller. The ring provides support to the valve so it can close more
tightly.
Septal Occluders
These devices are used to correct congenital heart defects. These defects generally include atrial septal defect,
ventricular septal defect, and the patent foramen ovale.
Atrial Septal Defect (ASD) Occluders
ASD occluder is used to close the abnormal hole in the wall of the upper chambers of the heart where the wall
between the right and left atria does not close completely. One unit refers to one ASD occluder.
Ventricular Septal Defect (VSD) Occluders
VSD occluder is used to close the defect in the ventricular septum. One unit refers to VSD occluder.
Patent Foramen Ovale (PFO) Occluders
PFO occluder is used to close the defect in the septum (wall) between the two upper (atrial) chambers of the heart.
One unit refers to one PFO Occluder.
Cardiovascular Surgery
This includes devices used in cardiovascular surgeries such as coronary artery bypass surgery. The category
includes devices and accessories used to aid in cardiovascular surgery.
Beating Heart Surgery Systems
Beating heart surgery systems are a new technique of cardiac surgery in which the heart continues to beat at its
normal rhythm during the surgery. This segment consists of positioners and stabilizers.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 20
Positioners
Positioners guide and hold the heart in a position that provides the best access to the blocked arteries. One unit
refers to one positioner.
Stabilizers
Stabilizers hold a small area of the heart still while a surgeon works on it. One unit refers to one stabilizer.
Cardiac Ablation Devices
Cardiac ablation devices are used to treat the atrial fibrillation by disrupting the abnormal pathways using
RF/Microwave energy or intense cold (cryoablation). Electrophysiology (EP) ablation is not tracked under this
segment. The system includes radiofrequency (RF) generator, remote control console and irrigation pump. One unit
refers to one cardiac ablation device consisting of the above mentioned devices.
Cardiopulmonary Bypass Equipment
Cardiopulmonary bypass equipment consists of the capital equipment used during cardio pulmonary bypass surgery.
This includes the heart-lung machine. One unit refers to one heart-lung machine.
Perfusion Disposables
Perfusion disposables consist of the disposable items used during cardio pulmonary bypass surgery. These include
custom packs and oxygenators. One oxygenator and one custom tubing pack are used for each on-pump procedure.
Custom Tubing Packs
Custom Tubing Packs are made from non-toxic medical grade P.V.C. tubing, and are used exclusively in combination
with heart lung machine and other devices of the system, such as oxygenator, blood cardioplegia delivery system.
The set is used exclusively for supply of blood & other liquids between the patient & extracorporeal system. A custom
tubing pack usually consists of tubing, connectors, fittings and monitoring cells. One unit refers to one custom tubing
pack.
Oxygenators
Oxygenators are devices in which blood and oxygen are separated by a semi-permeable membrane, generally of
Teflon or polypropylene, across which gas exchange occurs. These devices are used along with heart-lung machines
during cardiopulmonary bypass surgery. One unit refers to one oxygenator.
Electrophysiology
Electrophysiology equipment analyzes the electrical activity of the heart. The equipment is used with cardiac
catheters and sophisticated computers to generate electrocardiogram tracings and electrical measurements with
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 21
exquisite precision from within the heart chambers. RF generators may be used in conjunction with electrophysiology
equipment to treat the abnormal impulse generating areas in the heart.
Electrophysiology Ablation Catheters
Electrophysiology ablation catheter is a catheter with an electrode on one end that emits mild radiofrequency energy
to destroy a small area of heart tissue in the abnormal pathway, preventing any further transmission of the impulses
causing the arrhythmia. Standard and advanced ablation catheters have been tracked under this segment.
Advanced Ablation Catheters
Advanced ablation catheters include irrigational tip catheters, cryo ablation catheters, laser ablation catheters and
navigational catheters. Navigational catheters are used in advance mapping devices which are not tracked under this
category. One unit is defined as one advanced ablation catheter.
Standard Ablation Catheters
Standard ablation catheter is a normal tip catheter (4mm-8mm) which is used in electrophysiology devices. One unit
is defined as one standard ablation catheter.
Electrophysiology Diagnostic Catheters
Electrophysiology diagnostic catheter is a tube with an electrode that is threaded through an artery into the heart
where it both records electrical activity and emits electrical impulses to test the heart‟s response. This test helps
doctors identify rhythm problems and pinpoint areas of the heart responsible for abnormal heart rates. One unit refers
to one electrophysiology diagnostic catheter. Standard and advanced diagnostic catheters have been tracked under
this segment.
Advanced Diagnostic Catheters
Advanced diagnostic catheters include pulmonary vein catheters (loop catheters). Ultrasound catheters are not
tracked under this category. One unit is defined as one advanced diagnostic catheter.
Standard Diagnostic Catheters
Standard diagnostic catheters include fixed and steerable diagnostic catheters. One unit is defined as one standard
diagnostic catheter.
Electrophysiology Lab Systems
Electrophysiology Lab Systems are used for the visualization, diagnosis and treatment of cardiac arrhythmias.
Electrophysiology lab systems include Advanced Mapping Systems, EP Recording Systems, X-ray Systems,
Intracardiac Echocardiography Systems, Radiofrequency Ablation Generators, EP Stimulators, Remote Navigation
Systems and Cryoablation Consoles. Only complete installations of Electrophysiology lab systems are tracked here.
One unit refers to one Electrophysiology lab system.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 22
External Defibrillators
External defibrillators are emergency medical devices that are predominantly used to diagnose life-threatening
abnormalities such as irregular heart rhythms (cardiac arrhythmia), and treat these conditions by delivering electrical
energy to the heart to restore its normal rhythm. These devices are used in emergency situations on the patients who
have suffered or collapsed due to sudden cardiac arrest. They are ideally used within a few minutes of the collapse.
Manual Defibrillators
Manual external defibrillators are used with an electrocardiogram display or have a built - in electrocardiogram to
diagnose the rhythm of the heart. On the basis of the diagnosis, the clinician then determines the energy amount to
be delivered to the patient. These devices are predominantly used in hospitals and in some ambulances with
doctors/physicians/skilled paramedics onboard.
Public Access AED
Public access AED's provide clear voice prompts that instruct users through the lifesaving cycle including prompts to
perform CPR, and step-by-step instructions on how to use the AED. It comes along with pads and connecting cables.
One unit refers to one public access AED defibrillator with a set of pads and connecting cables.
Professional AED
Professional AED's display the victim's heart rhythm on a built-in high resolution color ECG display and give
professional users the option of delivering defibrillation shocks either semi-automatically or manually during the
emergency treatment of a victim of sudden cardiac arrest. It comes along with pads and connecting cables. One unit
refers to one professional AED defibrillator with a set of pads and connecting cables.
Interventional Cardiology
Interventional cardiology includes devices used to diagnose and treat diseases related to the coronary artery using a
minimally invasive procedure. These include coronary stents, cardiac catheters, Percutaneous Transluminal Coronary
Angioplasty (PTCA) Balloons, coronary guidewires, Intravascular Ultrasound Systems (IVUS) and arteriotomy closure
devices. Electrophysiology products are not covered under this category.
Arteriotomy Closure Devices
Arteriotomy closure devices are used for carrying out hemostasis at the end of a percutaneous intervention (PCI).
This is used as an alternative to manual or mechanical compression. Radial access devices and femoral access
devices have been tracked under this segment.
Femoral Access Devices
Femoral closure devices are used for the percutaneous closure of common femoral artery access sites in patients
who have undergone diagnostic endovascular catheterization devices. Hemostasis is carried out by these devices
either by a clip, titanium staple or by an absorbable sealant. One unit refers to one femoral closure device.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 23
Radial Access Devices
Radial closure devices provide controlled compression of the radial artery without completely occluding vessel flow. It
consists of a transparent cuff, the air injection port, inflator and an adjustable band. One unit refers to one radial
closure device.
Cardiac Catheters
Cardiac catheters are narrow hollow tubes used for guiding and visualization of the coronary vasculature or the
functioning of heart valves. Cardiac catheters include guiding catheters and angiography catheters.
Angiography Catheters
Angiography catheters are used to administer a radio contrast dye into the chambers of the heart to detect any
abnormalities related to the coronary arteries or cardiac valves. One unit refers to one angiography catheter.
Guiding Catheters
Guiding catheters are catheters used to navigate stents, balloons and leads during a minimally invasive procedure.
One unit refers to one guiding catheter.
Coronary Guidewires
A coronary guidewire is used to navigate catheters during percutaneous coronary interventions (PCIs). The guidewire
has an elongated body for a degree of flexibility and a distal tip. One unit refers to one coronary guidewire
Coronary Stents
A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a
disease-induced localized flow constriction. The main goal of the stent is to hold the inner wall in its compressed
position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include
Bare Metal Stents (BMS) and Drug Eluting Stents (DES).
Bare Metal Stents
Bare metal stents (BMS) are uncoated stents that are permanently placed inside the artery. These stents are
constructed from a range of metals, including nitinol, stainless steel, and cobalt chromium. One unit refers to one bare
metal stent.
Drug Eluting Coronary Stents
Drug Eluting Stent (DES) is a BMS that releases drugs locally and can be coated with a polymeric material. The stent
releases an anti-proliferative or immunosuppressive drug over time, leaving behind the metallic stent in the artery.
One unit refers to one drug eluting stent.
Intravascular Ultrasound Systems
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 24
Intravascular ultrasound system is a fiber-optic, catheter-based, near-infrared (NIR) spectroscopy and intravascular
ultrasound combined system intended to identify and characterize atherosclerotic plaque in the coronary arteries. It is
a combination device that uses IVUS to quantify the degree of narrowing produced by a plaque, the size of the artery
and the adequacy of stent expansion.
Intravascular Ultrasound Catheters
Intravascular ultrasound catheter is an imaging catheter intended for evaluation of vascular morphology in blood
vessels of the coronary and peripheral vasculature. It provides cross-sectional image of such vessels. It incorporates
a cylindrical ultrasound transducer array used to radiate acoustic energy into the surrounding tissue and detects the
subsequent ultrasonic echoes. The information from the echoes is used to generate real-time images of the coronary
and peripheral vessels. One unit refers to one Intravascular Ultrasound Catheter.
Intravascular Ultrasound System Consoles
Intravascular Ultrasound System Console is the base unit which is integrated into the interventionalist lab with the
control panel, CPU, Color LCD Monitor, patient interface module for catheter designed to hang on bed rail. One unit
refers to one Intravascular Ultrasound System Consoles.
Percutaneous Transluminal Coronary Balloon (PTCA) Balloons
Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon catheters are used to restore blood flow in
occluded coronary arteries and deliver stents. PTCA balloons include Rapid Exchange (RX), Over-the-Wire, Fixed
Wire (FW) and Cutting and Scoring balloons.
Fixed Wire (FW) Balloon
A fixed wire angioplasty balloon catheter is an elongated, flexible, thin walled metal tube with an inflatable balloon on
the distal end. A FW PTCA catheter is used to compress plaque and dilate (widen) narrowed coronary arteries to
restore normal blood flow. This is often accompanied by implanting an expandable metal stent. One unit refers to one
FW balloon catheter.
Over the Wire Balloons
An over-the-wire balloon catheter consists of two lumens including one for the guidewire and the other for balloon
inflation. An over-the-wire PTCA catheter can be used compress plaque and dilate (widen) narrowed coronary
arteries to restore normal blood flow. This is often accompanied by implanting an expandable metal stent. One unit
refers to one over the wire balloon catheter.
PTCA Cutting and Scoring Balloons
Cutting and scoring balloon catheters have microsurgical blades mounted longitudinally on the angioplasty balloon
catheter. They can be advanced through occluded coronary arteries and used for plaque debulking. Cutting and
scoring balloon catheters exert less pressure compared with that by conventional balloon angioplasty catheters. One
unit refers to one PTCA cutting and scoring balloon catheter.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 25
Rx Balloons
An Rx balloon catheter has an elongated shaft, two lumens for balloon inflation and guidewire and a proximal and
distal shaft. An angioplasty balloon is located on the distal shaft of the catheter. A Rx PTCA catheter is used to
compress plaque and dilate (widen) narrowed coronary arteries to restore normal blood flow. One unit refers to one
Rx balloon catheter.
PTCA Drug Eluting Balloons (DEB)
A drug eluting balloon (DEB) is an anti-restenotic drug coated PTCA (Percuatneous Transluminal Coronary
Angioplasty) balloon intended to prevent re-narrowing of the coronary arteries. DEBs provide fast, short-term,
homogenous, local drug delivery, preserve the anatomy of the vessel, promote enhanced vessel healing, and reduce
the need for prolonged dual anti-platelet therapy without leaving any metal behind. They can be used for coronary
and peripheral artery applications including treating in-stent restenosis (ISR), bifurcations, small vessels, and long
lesions. One unit refers to one PTCA drug eluting balloon.
Peripheral Vascular Devices
Peripheral vascular devices include devices used to treat peripheral vascular disease (PVD). These include
peripheral vascular stents, peripheral non vascular stents, peripheral guidewires, percutaneous transluminal
angioplasty (PTA) balloons, grafts (allograft and artificial) and embolic protection devices.
Inferior Vena Cava Filter (IVCF)
Inferior Vena Cava Filter (IVCF) is used to prevent emboli from reaching lungs which results in Pulmonary Embolism
(PE). It includes Retrievable IVCF and Permanent IVCF.
Permanent IVCF
Permanent IVCF are the one's which cannot be removed or repositioned. One unit refers to one Permanent IVCF.
Retrievable IVCF
Temporary or retrievable IVCF are the one‟s which can be retrieved or repositioned up to a certain point of time. It
includes both temporary filters that must be retrieved and retrievable filters where retrieval is optional. One unit refers
to one Retrievable IVCF.
Peripheral Embolic Protection Devices
Peripheral Embolic Protection devices prevent the emboli or other debris from blocking and disrupting blood flow in
the body. Carotid, renal and lower extremity embolic protection devices have been tracked under this segment.
Carotid Embolic Protection Devices
Carotid embolic protection devices are used to prevent the debris from reaching the brain during carotid angioplasty.
One unit refers to one embolic protection device used in carotid angioplasty.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 26
Renal Embolic Protection Devices
Renal embolic protection devices are used to prevent the debris from reaching the kidney while placing a stent in the
renal artery. One unit refers to one renal embolic protection device.
Lower Extremity Embolic Protection Devices
Lower extremity embolic protection devices are used during lower extremity interventions. One unit refers to one
lower extremity embolic protection device.
Peripheral Guidewires
Peripheral Guidewires are used during the percutaneous transluminal angioplasty and angiography for guiding the
stents or catheters to the site of action in the peripheral vasculature. Hydrophilic and Non-hydrophilic peripheral
guidewires are tracked under this segment.
Hydrophilic Peripheral Guidewires
Hydrophilic peripheral guidewires are coated with hydrophilic coating which provides maximum lubricity and helps to
facilitate catheter navigation. One unit refers to one hydrophilic peripheral guidewire.
Non-Hydrophilic Peripheral Guidewires
Non-hydrophilic peripheral guidewires are peripheral guidewires which do not have a hydrophilic coating and may
include other coatings such as PTFE, silicone etc. One unit refers to one peripheral guidewire.
Peripheral Vascular Stents
Peripheral Vascular Stent is an expandable perforated tube that is inserted into a peripheral vessel to prevent blood
flow constriction. Carotid artery stents, Iliac Artery Stents, Infrapop Artery Stents, Renal Artery stents and Fem-pop
Artery stents, are covered under this segment.
Carotid Artery Bare Metal Stents
A carotid artery stent is the tube that is inserted in the Carotid artery, to increase the flow of blood blocked by plaque.
It is generally recommended for people who are unable to undergo an endarterectomy. Only Bare Metal Stents are
tracked under this sub-segment, as majority of the surgeries use Bare Metal Stents for Carotid Artery Stenting. One
unit refers to one Carotid Artery Bare Metal Stent.
Renal Artery Bare Metal Stents
Renal stent is a tube that is inserted in the renal arteries to increase blood flow to kidneys. Only Bare Metal Stents are
tracked under this sub-segment, as majority of the surgeries use Bare Metal Stents for the Renal Artery Stenting. One
unit refers to one Renal Artery Bare Metal Stent.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 27
Fem-pop Artery Stents
A Fem-pop Stent is a tiny, expandable metal coil that is inserted into the femoral and popliteal arteries located in thigh
and knee during the femoropopliteal artery stenting devices. Fem-pop Artery Stents are further segmented into;
Fem-pop Artery Bare Metal Stents
Fem-pop Artery Bare-metal stent is a stent without a coating. It is a mesh-like tube of thin wire. One unit refers to one
Fem-pop Artery Bare Metal Stent.
Fem-pop Artery Drug Eluting Stents
Fem-pop Artery Drug-Eluting stent is coated with a medicine or drug that helps further prevent the arteries from re-
closing. One unit refers to one Fem-pop Artery Drug Eluting Stent.
Fem-pop Artery Covered Stents
Fem-pop Artery Covered Stent is a flexible tube used to repair or support a damaged section of an artery. These
stents are made up of a metallic frame which is covered by durable fabric. One unit refers to one Fem-pop Artery
Covered Stent.
Fem-pop Artery Bio-absorbable Stents
Fem-pop Artery Bio-absorbable Stent is manufactured from a material that may dissolve or be absorbed in the body.
One unit refers to one Fem-pop Artery Bio-absorbable Stent.
Iliac Artery Stents
An Iliac artery stent is the tube that is inserted in the Iliac artery to increase the flow of blood in the narrowed iliac
arteries. Iliac Artery Stents are further segmented into;
Iliac Artery Bare Metal Stents
lliac Artery Bare-metal stent is a stent without a coating. It is a mesh-like tube of thin wire. One unit refers to one Iliac
Artery Bare Metal Stent.
Iliac Artery Drug Eluting Stents
liac Artery Drug-Eluting stent is coated with a medicine or drug that helps further prevent the arteries from re-
closing. One unit refers to one Iliac Artery Drug Eluting Stent.
Iliac Artery Covered Stents
Iliac Artery Covered Stent is a flexible tube used to repair or support a damaged section of an artery. These stents
are made up of a metallic frame which is covered by durable fabric. One unit refers to one Iliac Artery Covered Stent.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 28
Iliac Artery Bio-absorbable Stents
Iliac Artery Bio-absorbable Stent is manufactured from a material that may dissolve or be absorbed in the body. One
unit refers to one Iliac Artery Bio-absorbable Stent.
Infrapop Artery Stents
An Infrapop Stent is a tiny, expandable metal coil that is inserted to establish flow in the tibial, peroneal or pedal
arteries. Infrapop Artery Stents are further classified into;
Infrapop Artery Bare Metal Stents
Infrapop Artery Bare-metal stent is a stent without a coating. It is a mesh-like tube of thin wire. One unit refers to one
Infrapop Artery Bare Metal Stent.
Infrapop Artery Drug Eluting Stents
Infrapop Artery Drug-Eluting stent is coated with a medicine or drug that helps further prevent the arteries from re-
closing. One unit refers to one Infrapop Artery Drug Eluting Stent.
Infrapop Artery Covered Stents
Infrapop Artery Covered Stent is a flexible tube used to repair or support a damaged section of an artery. These
stents are made up of a metallic frame which is covered by durable fabric. One unit refers to one Infrapop Artery
Covered Stent.
Infrapop Artery Bio-absorbable Stents
Infrapop Artery Bio-absorbable Stent is manufactured from a material that may dissolve or be absorbed in the body.
One unit refers to one Infrapop Artery Bio-absorbable Stent.
Renal Denervation Disposable Catheters
Renal Denervation is a catheter based specialized ablation procedure used to reduce blood pressure in patients with
hypertension, or who are resistant to medical therapy. During this procedure, Radio Frequency (RF) energy is
delivered to the renal artery using a catheter with a RF energy electrode tip. This ablation delivered to the renal artery
disrupts the renal nerves resulting in reduction of blood pressure. One unit refers to one Renal Denervation
Disposable Catheter.
PTA Balloons
Percutaneous Transluminal Angioplasty (PTA) balloon catheters are used to compress plaque and dilate the arterial
wall to restore normal blood flow through the vessel. A PTA balloon catheter has a small folded balloon at the end of
the catheter. One unit refers to one PTA balloon catheter.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 29
PTA Peripheral Drug Eluting Balloons (DEB)
A Drug Eluting Balloon (DEB) is an anti-restenotic drug coated PTA (percutaneous transluminal angioplasty) balloon
intended to prevent re-narrowing of the peripheral arteries. DEBs provide fast, short-term, homogenous, local drug
delivery, preserve the anatomy of the vessel, promote enhanced vessel healing, and reduce the need for prolonged
dual antiplatelet therapy without leaving any metal behind. One unit refers to one PTA peripheral DEB.
Aortic Stent Grafts
Aortic Stent grafts are used to surgically reinforce a part of the diseased aorta such as blood filled dilation and are
used in cases that cannot be treated with intervention. It can be an allograft or a poly tetra fluro ethylene (PTFE) type.
These include thoracic aortic stent grafts and abdominal aortic stent grafts.
Abdominal Aortic Stent Grafts
Abdominal aortic stent grafts are used to treat abdominal aortic aneurysms by reinforcing a part of the aorta using a
minimally invasive procedure. One unit refers to one abdominal stent graft.
Thoracic Aortic Stent Grafts
Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a
minimally invasive procedure. One unit refers to one thoracic aortic stent graft.
Vascular Grafts
Vascular grafts are used to repair or replace blood vessels in surgical devices. They are made up of Dacron or
polytetrafluroethylene (PTFE). It is also used to patch injured or diseased areas of arteries, for replacement of whole
segments of larger arteries such as the aorta. One unit refers to one vascular graft. In the taxonomy only synthetic
vascular grafts are tracked, thus preserved autologous grafts from other veins and arteries, cryo-preserved veins,
xenografts, arterial homograft are excluded from the analysis.
Peripheral Venous Thrombectomy Devices
Peripheral venous thrombectomy devices are the type of clot busting devices that are used to treat thrombus
containing lesions developed due to peripheral insufficiency. Mechanical Thrombectomy devices and Aspiration
Thrombectomy devices are tracked under this category:
Mechanical Thrombectomy Devices
Mechanical thrombectomy device involves the use of rotating coil which mechanically breaks the clot, sucking the
debris out through the catheter from the peripheral vasculature by negative pressure. One unit of mechanical
thrombectomy device consists of a catheter and a driving unit with a rotating coil to which the catheter is attached.
Aspiration Thrombectomy Devices
This type of thrombectomy device involves the application of negative pressure for the removal of thrombus from the
peripheral vasculature. The pressure is applied at the distal end of the catheter which leads to aspiration of the clot
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 30
into the catheter. One unit of aspiration thrombectomy device consists of a catheter and a driving unit to which the
catheter is attached.
Prosthetic Heart Valves
Prosthetic heart valve is a device which mimics the function of human heart valves and have a passive mode of
functioning; opening and closing of valves are responses to pressure and flow changes within the heart. They are for
the patients that have a heart valvular disease where they need their valve to be replaced. Prosthetic heart valves
include both mechanical and tissue or biological heart valves.
Mechanical Heart Valves
Mechanical heart valves are generally made of non–physiological materials with a mobile occluder, which is made of
rigid materials.
Mechanical Aortic Valve Replacements
This includes replacement of the aortic heart valve using a mechanical prosthesis. One unit refers to one mechanical
aortic valve.
Mechanical Mitral Valve Replacements
This includes replacement of the mitral heart valve using a mechanical prosthesis. One unit refers to one mechanical mitral valve replacement.
Tissue Heart Valves
Tissue heart valve are a combination of tissue and synthetic biomaterials with the tissue itself being flexible. Bovine
and porcine valves are included here.
Tissue Aortic Valve Replacements
This includes replacement of the aortic heart valve using a biological prosthesis. One unit refers to one tissue aortic
valve.
Tissue Mitral Valve Replacements
This includes replacement of the mitral heart valve using a biological prosthesis. One unit refers to one tissue mitral
valve.
Transcatheter Heart Valves
The Transcathetar heart valve is a tissue valve replacement that can be compressed down to the diameter of a
pencil. It can be placed inside a beating heart using a catheter threaded through the patient's circulatory system or
through a small incision between ribs. Once inside the heart, the valve can then be opened into its natural position by
inflation of a balloon and deployed within the patient's diseased aortic valve. Only Aortic valve replacements are
tracked here. One unit refers to one Transcathetar heart valve.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 31
3 Cardiovascular Devices Market, India
3.1 Cardiovascular Devices Market, India, Revenue ($m), 2005-2020
Figure 1: Cardiovascular Devices Market, India, Revenue ($m), USD Constant, 2005-2020
Source: GlobalData
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 32
Table 1: Cardiovascular Devices Market, India, Revenue ($m), USD Constant, 2005-2020
Category 2005 2012 2020 CAGR 05-12 CAGR 12-20 CAGR 05-20
Interventional Cardiology
Peripheral Vascular Devices
Cardiac Rhythm Management
Prosthetic Heart Valves
Cardiovascular Surgery
Electrophysiology
Cardiovascular Monitoring and Diagnostic Devices
External Defibrillators
Cardiac Assist Devices
Cardiovascular Prosthetic Devices
Total
Source: GlobalData
.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 33
3.2 Cardiovascular Devices Market, India, Revenue Mix ($m), 2012
Figure 2: Cardiovascular Devices Market, India, Revenue Mix ($m), 2012
Source: GlobalData
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 34
3.3 Cardiovascular Devices Market, India, Category Contribution by Revenue ($m), 2012
Figure 3: Cardiovascular Devices Market, India, Category Contribution (%), 2012
Source: GlobalData
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 35
Table 2: Cardiovascular Devices Market, India, Category Contribution by Revenue ($m), 2012
Category Revenue ($m) Contribution Revenue (%) Contribution
Interventional Cardiology
Peripheral Vascular Devices
Cardiac Rhythm Management
Prosthetic Heart Valves
Cardiovascular Surgery
Electrophysiology
Cardiovascular Monitoring and Diagnostic Devices
External Defibrillators
Cardiac Assist Devices
Cardiovascular Prosthetic Devices
Source: GlobalData
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 199
18 Appendix
The data and analysis within this report are driven by Medical eTrack. Medical eTrack gives you the key information
required to drive sales, investment and deal-making activity in your business. It includes the following:
15,000+ data tables showing market size across more than 780 medical equipment segments and 15 countries,
from 2005 and forecast to 2020
6,000+ primary expert interviews, conducted annually to ensure data and report quality
1,100+ medical equipment conference reports
1,000+ industry-leading reports per annum, covering growing sectors, market trends, investment opportunities
and competitive landscape
600+ analysis reports, covering market and pipeline product analysis, by indication; medical equipment trends
and issues, and investment and M&A trends worth over $3m
50,000+ medical equipment company profiles
2,000+ private, emerging and technology start-up company profiles
4,000+ company profiles of medical equipment manufacturers in China and India
2,000+ company profiles of medical equipment manufacturers in Japan
825+ companies‟ revenue splits and market shares
1,100+ quarterly and annual medical equipment company financials
700+ medical equipment company SWOTs
11,700+ pipeline product profiles
14,000+ marketed product profiles
16,900+ clinical trials
17,000+ trial investigators
18,000+ new product patents
3,700+ reports on companies with products in development
21,500+ reports on deals in the medical equipment industry
1,300+ surgical and diagnostic procedures by therapy area
50+ key healthcare indicators by country
For more information or to receive a free demonstration of the service, please visit:
http://www.medicaletrack.com/ContactUs.aspx?Id=RequestDemo
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 200
18.1 Research Methodology
GlobalData‟s dedicated research and analysis teams consist of experienced professionals with advanced statistical
expertise and marketing, market research and consulting backgrounds in the medical devices industry.
GlobalData adheres to the codes of practice of the European Pharmaceutical Marketing Research Association
(http://www.ephmra.org/).
All GlobalData databases are continuously updated and revised.
18.1.1 Coverage
The objective of updating GlobalData‟s coverage is to ensure that it represents the most up-to-date vision of the
industry possible.
Changes to the industry taxonomy are built on the basis of extensive research of company, association and
competitor sources.
Company coverage is based on three key factors: revenue; product and media attention; and innovation and market
potential.
The estimated revenue of all major companies, both private and public, are gathered and used to prioritize coverage.
GlobalData aims to cover all major news events and deals in the medical devices industry, updated on a daily basis.
The coverage is further streamlined and strengthened with additional input from GlobalData‟s expert panel.
18.1.2 Secondary Research
The research process begins with extensive secondary research using internal and external sources to gather all
relevant data and information pertaining to a particular market model for a particular country. The secondary research
sources that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Industry trade journals, scientific journals and other technical literature
Association and healthcare organization websites
PubMed, Medscape and other relevant services which compile extensive reviews of clinical literature
Internal proprietary databases
Relevant patent and regulatory databases
National government documents, statistical databases and market reports
Procedure registries
News articles, press releases and web-casts specific to the companies operating in the market
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 201
18.1.3 Primary Research
GlobalData conducts interviews with industry participants and commentators in order to validate its data and analysis.
A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape and
future outlook
Helps to validate and strengthen secondary research findings
Further develops the analysis team‟s expertise and market understanding
Primary research involves email correspondence, telephone interviews and face-to-face interviews for each market,
category, segment and sub-segment across a range of geographies.
The participants who typically take part in such a process include, but are not limited to:
o Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and
national sales managers
o Distributors, paramedics and representatives from hospital stores, laboratories and pharmacies
o Outside experts: investment bankers, valuation experts and research analysts that specialize in specific
medical equipment markets
o Key opinion leaders: physicians and surgeons that specialize in the therapeutic areas in which the
medical device is used
The market data was validated based on the inputs from 1,771 primary research participants. The primary research
participants included stakeholders from demand side such as the cardiovascular surgeons, as well as participants
from the supply side such as the marketing managers, sales managers and product managers of companies
manufacturing/marketing cardiovascular devices.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 202
Table 93: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country
Country Total Number of Primary Research Participants
United States 136
United Kingdom 120
Germany 128
France 153
Italy 121
Spain 134
Brazil 128
China 79
India 173
Russia 89
Japan 88
Australia 122
Canada 111
Mexico 90
South Korea 99
Total 1,771
Source: GlobalData
18.1.4 Market Modeling and Forecasting
GlobalData uses an epidemiology-based treatment flow model and capital equipment-based model to estimate and
forecast market size.
Epidemiology-Based Market Model and Forecasting
The epidemiology-based forecasting model uses epidemiology data gathered from research publications and primary
interviews with physicians to establish the target patient population and treatment flow pattern for individual diseases
and therapies. The data covers prevalence, incidence, diseased population, diagnosed population, and treatment
population.
The market forecast begins with the general population, the size of which varies depending on the indication.
Prevalence is the percentage of the total population that suffers from a particular disease or condition.
Incidence is the number of new cases of a condition, symptom, death or injury that develop during a specific
time period, such as one year.
The diseased population is the population suffering from a particular disease or condition.
The diagnosed population is the population that has been diagnosed with a particular disease or condition,
expressed as a percentage of the prevalence population.
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 203
The treatment population is the percentage of the population that has been diagnosed with a particular
disease or condition.
Device uptake is the percentage of the treatment population using a particular device, determined based on
the primary responses and the information available in secondary sources.
The epidemiology-based forecasting model for a medical device is used to:
Determine the patient segment using a particular device or procedure
Determine the frequency of usage of a particular device depending on the patient type, which further helps to
determine the absolute unit sales of a device in a year
The market for any medical device is directly proportional to the volume of units sold and the price per unit.
Market size = volumes of units sold X ASP (Average Selling Price)
The volume of units sold is calculated from the number of patients using or that has been implanted with the device.
Data on treatment rate, diagnosis and surgical treatment rate, if unavailable from research publications, is gathered
from interviews with physicians and used to estimate the patient volume for the disease under consideration.
The ASP of a device is mostly gathered from primary and secondary sources. ASP is the price at which a device is
available in a target country to an end-user. For capital equipment, the end-user is typically considered to be the
healthcare setting. For implants and consumables purchased by patients, the end-user is the patient.
Factors such as company share, reimbursement, company type (local/domestic or multinational) are taken into
consideration during ASP analysis, which uses the following sources:
Company websites
Annual reports/industry reports
Press releases
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 204
Epidemiology-Based Forecasting Model
Capital Equipment-Based Market Model and Forecasting
The capital equipment-based forecasting model is based on the installed base, replacements and new sales of a
specific type of capital equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. The
installed base is calculated from the average number of units per facility. Sales for a particular year are arrived at by
calculating the number of replacement units and new units (additional and first-time purchases). Secondary sources
and interviews with supply-side participants and key opinion leaders from healthcare facilities are used to arrive at
installed base and unit sales for a particular year. The factors typically affecting the forecast growth rates are:
Growth in the number of healthcare facilities
Healthcare spending and government programs and initiatives
Migration from low-end equipment to high-end equipment
Growth in the diagnosed population and treatment population
Figure 77: GlobalData Epidemiology-Based Forecasting Model
Source: GlobalData
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 205
Capital Equipment-Based Forecasting Model
18.1.5 Company Share Analysis
Company shares are calculated by analyzing a company‟s sales in a particular market. In the case of public
companies, annual reports and regulatory filings, investor presentations, earnings call transcripts and broker reports
are used to determine a company‟s revenue in a particular market and in a particular geography.
In the case of the private companies, company share data is gathered mostly from primary interviews and secondary
sources. Company share analysis is based on primary interviews with:
Supply side (manufacturers)
Procurement side
Distributors
Hospital purchasing groups
Demand side (surgeons/specialists)
Figure 78: GlobalData Capital Equipment-Based Forecasting Model
Source: GlobalData
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 206
The benefits of this approach are:
High number of respondents to validate and from which to derive accurate company shares
Broad view from the supply, demand, and procurement side
Prevents biased opinions being reproduced
Demand-side interviews with key opinion leaders help to understand their preferences for the devices of
specific companies, strengthening company share estimates
Primary Interviews by Participant Type
Figure 79: Primary Interviews by Participant Type (%)
The final company share data is based on input from the supply side, the procurement side and the demand side, as
well as secondary sources. Please note that market share for companies that are included under the „Others‟
category is not tracked on an individual basis.
18.1.6 Distribution Share Analysis
Distribution share information is gathered using a combination of secondary and primary research. It is supported by
primary interviews because the availability of secondary data is limited in most cases.
18.2 Expert Panel
GlobalData uses a panel of experts to cross-verify its databases and forecasts.
GlobalData‟s expert panel comprises marketing managers, product specialists, international sales managers from
medical device companies, academics from research universities, key opinion leaders from hospitals, consultants
from venture capital funds and distributors/suppliers of medical equipment and supplies.
Historic data and forecasts are relayed to GlobalData‟s expert panel for feedback and adjusted accordingly.
50
25
25
Procurement side Supply side Demand side
SAMPLE
India Cardiovascular Devices Market Outlook to 2020 GDMEMC0040DB / Published May 2014
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Page 207
18.3 GlobalData Consulting
We hope that the data and analysis in this brief will help you to make informed and imaginative business decisions. If
you have further requirements, GlobalData‟s consulting team may be able to help you. GlobalData offers tailor-made
analytical and advisory services to drive your key strategic decisions.
18.5 Disclaimer
All Rights Reserved.
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,
electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher,
GlobalData.
SAMPLE
top related